|1.||Reis, O: 3 articles (01/2014 - 11/2008)|
|2.||Glaser, T: 3 articles (01/2014 - 11/2008)|
|3.||Rubio, Gabriel: 3 articles (12/2009 - 06/2002)|
|4.||Reis, Olaf: 2 articles (12/2014 - 05/2007)|
|5.||Wichowicz, Hubert M: 2 articles (07/2013 - 04/2007)|
|6.||Kumar, Ajit: 2 articles (01/2012 - 09/2009)|
|7.||Hässler, F: 2 articles (11/2011 - 11/2008)|
|8.||Mackeprang, Torben: 2 articles (02/2007 - 05/2004)|
|9.||Alamo, Cecilio: 2 articles (07/2006 - 06/2002)|
|10.||Fenton, M: 2 articles (01/2004 - 01/2000)|
|1.||Schizophrenia (Dementia Praecox)
11/01/1986 - "The results of the study show a good efficacy of the drug in manic and schizophrenic disorders, Cisordinol being well tolerated intravenously. "
08/01/1998 - "An open label trial was conducted to study the efficacy of zuclopenthixol decanoate, a D(1)/D(2) antagonist, in the treatment of chronic (> 10 years) neuroleptic-resistant aggressive schizophrenia (n = 10) and psychotic oligophrenic patients (n = 6). "
01/01/2000 - "This review highlights the need for good controlled clinical trials to fully address the effects of zuclopenthixol decanoate for those with schizophrenia. "
01/01/2000 - "Inclusion criteria were that the clinical study should be randomised, focus on people with schizophrenia or other serious mental illness with psychotic symptoms, and compare the use of zuclopenthixol decanoate to oral zuclopenthixol or other antipsychotic preparations. "
08/01/1972 - "A one-year trial of clopenthixol in chronic schizophrenia."
|2.||Mental Retardation (Idiocy)
11/01/2011 - "Zuclopenthixol proved to be safe and effective to keep a lower rate of aggressive behavior in adults with mental retardation also over a longer period of time."
11/01/2008 - "Zuclopenthixol proved to be safe and effective to keep a low rate of aggressive behaviour in adults with mental retardation."
01/01/2014 - "Therapeutic drug monitoring of zuclopenthixol in a double-blind placebo-controlled discontinuation study in adults with intellectual disabilities and aggressive behaviour."
11/01/2011 - "Effects of zuclopenthixol on aggressive disruptive behavior in adults with mental retardation--a 2-year follow-up on a withdrawal study."
11/01/2008 - "A double-blind placebo-controlled discontinuation study of zuclopenthixol for the treatment of aggressive disruptive behaviours in adults with mental retardation - secondary parameter analyses."
|3.||Substance-Related Disorders (Drug Abuse)
07/01/2006 - "This study aimed to compare the efficacy of long-acting risperidone and zuclopenthixol in subjects with schizophrenia and substance abuse. "
07/01/2006 - "Long-acting injectable risperidone was more effective than zuclopenthixol-depot in improving substance abuse and schizophrenia symptoms in subjects with dual diagnosis."
07/01/2006 - "Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity."
|4.||Psychotic Disorders (Schizoaffective Disorder)
07/01/1999 - "An open trial of zuclopenthixol in management of acute psychoses : a multicentered study."
08/07/1981 - "Clopenthixol (Sordinol, Ciatyl) in small dosage has been shown to be much more effective than all other types of therapy in the management of those psychoses. "
01/01/1981 - "Cis(Z)-clopenthixol and clopenthixol in the treatment of acute psychoses and exacerbations of chronic psychoses. "
01/01/1965 - "[Clopenthixol in the treatment of psychoses. "
08/07/1981 - "[Treatment of pharmacotoxic psychoses with clopenthixol in patients with Parkinson's disease (author's transl)]."
|5.||Alzheimer Disease (Alzheimer's Disease)
03/01/1996 - "[A preliminary study of low dosage zuclopenthixol depot in Alzheimer's disease]."
03/01/1996 - "We present the results we obtained after observing the effects of depot zuclopenthixol in six patients with probable Alzheimer's disease (based upon NINCDS-ADRDA criteria). "
03/01/1996 - "We consider depot zuclopenthixol at low doses as efficacious in treating persistent psychomotor agitation and/or psychotic manifestations of Alzheimer's disease. "
01/01/1981 - "The therapeutic effects in senile dementia of haloperidol and cis(Z)-clopenthixol were compared in a double-blind, double-dummy clinical 8-week study in 47 demented patients after wash-out periods of 3 weeks or less. "
01/01/1981 - "A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia."
|1.||Risperidone (Risperdal Consta)
|3.||Antipsychotic Agents (Antipsychotics)
|7.||clopenthixol acetate ester